Upon binding to these ligands, PD‐1 acts to inhibit T cells.14 PD‐L1 is expressed both by cancer cells and tumor‐infiltrating lymphocytes and upregulation of PD‐L1 on tumor cells is an adaptive mechanism to facilitate immune evasion. This evidence concerns the gene CD274 and cancer.